Market Research Report
Blood Glucose Monitoring Market in the US 2011-2015
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||247062|
|Published||Content info||46 Pages
|Blood Glucose Monitoring Market in the US 2011-2015|
|Published: July 5, 2012||Content info: 46 Pages||
This publication has been discontinued on November 12, 2015.
TechNavio's analysts forecast the Blood Glucose Monitoring Device market in the US to grow at a CAGR of 3.8 percent over the period 2011-2011. One of the key factors contributing to this market growth is the introduction of personal testing kits. The Blood Glucose Monitoring Device market in the US has also witnessed the adoption of continuous glucose monitoring systems. However, the unwillingness of diabetes patients to use blood glucose monitoring devices could pose a challenge to the growth of this market.
TechNavio's report, the Blood Glucose Monitoring Device Market in the US 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses on the US market; it also covers the Blood Glucose Test Strips, Blood Glucose Meters, and Lancets market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Bayer Healthcare, LifeScan Inc., Medtronic Inc., and Roche Diagnostics. Other vendors mentioned in the report: Abbott Laboratories, Arkray Inc., Braun Melsungen AG, Dexcom, GlySens Inc., Hainice Medical Inc., Nipro, Diagnostics Inc., Nova Biomedical, and Terumo Corporation.
You can request one free hour of analyst time when you purchase this report. Details provided within the report